Intent to Sole Source - Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH - CC

Contract Value

Not provided

Codes & Classification
Solicitation Number

NOI-OLAO-CC-27-000988

NAICS

339112 - Surgical and Medical Instrument Manufacturing

Classification Code

6515

Additional Details
Set Aside

NONE

Place of Performance

Bethesda, Maryland, UNITED STATES

SourceSAM
The National Institutes of Health Clinical Center (NIH-CC), located in Bethesda, Maryland, has issued a presolicitation notice indicating its intent to procure BD Mission™ Disposable Core Biopsy Instruments (semi-automatic, single-use) for use in Interventional Radiology (IR) image-guided core needle biopsy procedures. This procurement will be conducted on a sole source basis, with Bard Peripheral Vascular Inc. identified as the intended vendor. The statutory authority for this non-competitive acquisition is 41 U.S.C. 253(c)(1), as implemented by FAR 6.302-1, which allows for procurement from only one responsible source when no other supply or service will satisfy agency requirements. The BD Mission™ Disposable Core Biopsy Instrument is specifically designed for IR procedures, offering compatibility with the BD TruGuide™ Disposable Coaxial Biopsy Needle. The device is available in a range of gauges (14G–20G) and lengths (6–25 cm), enabling clinicians to accommodate various lesion depths and target sites. Key features include Advanced Echogenic Technology for improved ultrasound visibility, a Fire Ready Indicator, and penetration depth presets (10mm/20mm), all of which support precision and safety during biopsy procedures. The instruments are single-use, sterile, and intended for recurring, as-needed delivery via standard vendor shipment. The procurement falls under NAICS Code 339112 (Surgical and Medical Instrument Manufacturing) and Product Service Code 6515, reflecting its classification as a medical device acquisition. There are no set-aside requirements associated with this notice, and the opportunity is not restricted to any particular socioeconomic category. Interested parties who believe they can provide the required instruments are invited to submit a capability statement for consideration. All responses must reference NOI-OLAO-CC-27-000988 and be sent via email to Valerie Gregorio ([email protected]) by 12:00 PM Eastern Standard Time on November 8, 2026. The government will review all submissions received by the deadline, but the final determination regarding competition rests solely with the NIH-CC. This notice is not a request for proposal, and no solicitation documents are available at this time. Contractors evaluating this opportunity should note that the requirement is for recurring supply of sterile, single-use biopsy instruments with specific compatibility and performance features, to support ongoing clinical operations at the NIH Clinical Center. The procurement is governed by federal acquisition regulations and will remain constant in its scope and requirements throughout the contract lifecycle. For further information, contractors may refer to the official notice posted on SAM.gov (Opportunity ID: 7b7c0dfa215648d982b20334713d18d2) or contact the primary point of contact, Valerie Gregorio, at the email address provided.